Drug Loading Efficiency
Drug Loading Efficiency - Related Videos
07:32
Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
0 Views •
Cited by 11 •
2015
The goal of this protocol is to describe the preparation and characterization of physically entrapped, poorly water soluble drugs in micellar drug delivery systems composed of amphiphilic block copolymers.
10:28
An Injectable and Drug-loaded Supramolecular Hydrogel for Local Catheter Injection into the Pig Heart
0 Views •
Cited by 21 •
2015
Supramolecular hydrogelators based on ureido-pyrimidinones allow full control over the macroscopic gel properties and the sol–gel switching behavior using pH. Here, we present a protocol for formulating and injecting such a supramolecular hydrogelator via a catheter delivery system for local delivery directly in relevant areas in the pig heart.
11:31
Targeting Drugs to Larval Zebrafish Macrophages by Injecting Drug-Loaded Liposomes
0 Views •
Cited by 2 •
2020
Here, we describe the synthesis of drug-loaded liposomes and their microinjection into larval zebrafish for the purpose of targeting drug delivery to macrophage-lineage cells.
10:36
In Vitro Imaging and Quantification of the Drug Targeting Efficiency of Fluorescently Labeled GnRH Analogues
0 Views •
Cited by 1 •
2017
Selectively labeled fluorescent GnRH-I, -II and -III derivatives are reliable tools for tracking and quantifying their cellular uptake. This manuscript introduces experiments to visualize, quantify and compare the uptake efficiency of these GnRH conjugates in various cell lines.
06:40
Cost-Efficient Transcriptomic-Based Drug Screening
0 Views •
Cited by 2 •
2024
This protocol describes a workflow from ex vivo or in vitro cell cultures to transcriptomic data pre-processing for cost-effective transcriptome-based drug screening.
FAQs
Interactions between a therapeutic compound and the carrier can determine how much drug remains associated with the delivery system after preparation. The carrier’s composition may promote or limit incorporation through its material properties, while processing conditions can further alter these interactions. Examining these factors helps explain why otherwise similar formulations can produce different loading outcomes.
Carrier composition influences the available environment for drug incorporation and therefore affects loading performance across nanoparticles, microparticles, hydrogels, and other platforms. Changing the material formulation can alter drug–material interactions and the amount retained during preparation. In bioengineering studies, comparing compositions helps identify formulations that support more consistent dosing and useful release behavior.
Loading performance helps determine how consistently a delivery system contains the intended therapeutic amount. Because incorporated drug contributes to the formulation available for subsequent release, differences in loading can affect dose consistency and release behavior. These relationships make the metric useful for evaluating whether a bioengineered carrier is likely to support predictable therapeutic performance.
Researchers compare the mass of drug incorporated into a formulation with the initial drug mass used during preparation. Applying the same comparison across nanoparticles, microparticles, hydrogels, and other carriers creates a common basis for assessing formulations. This approach supports meaningful evaluation of how carrier composition and processing conditions influence incorporation rather than relying only on platform type.
Optimization should consider both the carrier formulation and the conditions used to prepare it. Researchers can compare how changes in material composition, drug–material interactions, and processing conditions alter the amount incorporated. Evaluating these variables together helps identify a preparation approach that reduces drug loss while maintaining a delivery system suitable for consistent formulation performance.
In bioengineering, the metric supports formulation comparison, process optimization, and assessment of dose consistency across delivery systems. Higher incorporation can reduce drug waste and may support more effective, scalable platforms. Its relevance extends across nanoparticles, microparticles, hydrogels, and related carriers, allowing researchers to connect preparation choices with release behavior and therapeutic delivery goals.